Hudson Litigation Capital is a specialist litigation finance institution. We deploy disciplined, risk-adjusted capital into commercial claims — through two carefully structured products that match each claimant's situation.
Hudson Litigation Capital is a private, specialist litigation finance institution. We deploy proprietary capital — not third-party fund capital — into carefully selected commercial disputes through two purpose-built products: Litigation Funding and Claim Purchase Funding.
HLC is not a law firm, an insurer, or a guarantor of legal outcomes. We are a capital partner. We do not direct litigation strategy, instruct counsel, or interfere in proceedings. Our role is to provide disciplined capital and then step back.
Every transaction is governed by a formal Investment Committee operating under a documented underwriting doctrine. Capital preservation is our first obligation — return generation is secondary. All engagements are conducted on a strictly confidential basis. HLC does not publicise its portfolio or the identity of any claimant.
"Capital preservation first. Non-interference always. Confidentiality without exception."
HLC deploys its own capital and makes its own decisions. We are not a fund manager, a broker, or an intermediary that packages or syndicates deals. When HLC approves a transaction, one institution — with one capital source and one underwriting standard — is committing to it.
HLC deploys its own capital — not investor funds. This means faster decision cycles, no external LP obligations, and a single, consistent underwriting standard.
HLC does not publicise funded matters, portfolio composition, or client identity. All engagements are conducted on a strictly confidential basis.
HLC does not direct legal strategy, instruct counsel, or participate in settlement decisions. Legal authority rests exclusively with the claimant and their retained counsel.
Every capital deployment is approved by a formal Investment Committee against a documented underwriting standard. No exceptions. No principal can approve a transaction unilaterally.
Capital is deployed through dedicated Special Purpose Vehicles (SPVs). Each matter is structurally isolated — the failure of one investment cannot propagate to the broader portfolio.
HLC operates across common law and civil law jurisdictions, with a particular focus on English courts, international arbitral institutions (ICC, LCIA, ICSID, SIAC), and Commonwealth jurisdictions. Cross-border enforcement and sovereign matters are within our scope.
HLC is a commercial litigation capital institution. Our mandate is defined and purposefully narrow. We fund complex, high-merit commercial disputes — and we do not deviate from that mandate regardless of projected return.
Contractual claims, fraud, misrepresentation, and breach of fiduciary duty at a commercial scale.
Shareholder oppression, corporate fraud, derivative actions, and complex equity structure disputes.
Matters before ICC, LCIA, ICSID, SIAC, and other major international arbitral institutions — at both the merits and enforcement stages.
Claims against solicitors, accountants, financial advisers, and other professionals involving significant measurable loss.
IP infringement, trade secret misappropriation, and commercial real estate litigation.
Post-award enforcement capital, asset tracing, and complex multi-jurisdictional recovery efforts — including sovereign debt and treaty arbitration matters.
The following categories are excluded without exception, regardless of projected return, claim size, or claimant profile. No Investment Committee vote can override these restrictions.
HLC does not fund consumer injury, product liability mass torts, or any personal claim brought in a consumer capacity.
Individual personal injury claims are outside HLC's mandate. This includes road traffic accidents, medical negligence, and workplace injury below commercial thresholds.
HLC does not fund criminal defence, criminal appeals, or any matter arising from a criminal investigation or prosecution of any nature.
Divorce, child custody, matrimonial asset disputes, and child support proceedings are entirely excluded.
Visa applications, asylum claims, deportation appeals, and related immigration matters are outside scope.
Mass claimant and class action structures are not standard HLC products. Any engagement would require specific Investment Committee approval and is treated as exceptional.
HLC will not deploy capital where the claimant, defendant, or jurisdiction appears on any applicable sanctions or high-risk jurisdiction list.
Not sure if your matter qualifies? Submit a brief, non-privileged summary to inquiries@hudsonlitcap.com. HLC bears its own preliminary review costs — there is no fee to enquire.
Each HLC product is purpose-built for a specific capital need. Every transaction is governed by the same doctrine: capital preservation first, non-interference always.
HLC advances capital to cover your legal costs on a non-recourse basis. You pay nothing unless you win. No fees, no upfront charges — ever.
A qualified investor acquires a commercial claim from its current owner. HLC funds the purchase price through the investor's dedicated SPV.
HLC's core product is the Litigation Funding Agreement. We advance capital to cover the legal costs of pursuing a commercial claim — expert fees, court costs, counsel disbursements — on a fully non-recourse basis.
If the claim succeeds, HLC recovers its capital and a return from the proceeds. If the claim fails, the claimant owes HLC nothing. No personal liability. No guarantees required.
"HLC charges no application fees, no underwriting fees, and no monitoring fees. Our return is success-only."
The LFA product is designed for commercial matters where the claim value and anticipated legal costs are of a scale appropriate for formal, institutional funding arrangements. Claimants with low-value or early-stage matters are encouraged to engage qualified legal counsel before making an enquiry.
All proceeds flow into a designated account and are distributed in a defined priority order set out in the Litigation Funding Agreement. HLC recovers its capital and agreed return before the remainder is distributed to the claimant.
The specific priority order, return structure, and distribution mechanics are agreed individually and documented in the LFA. Full terms are discussed with qualifying claimants during the underwriting process.
Under the CPF product, HLC provides acquisition capital to a qualified investor (the "Purchaser") to fund the purchase of a commercial legal claim from its current owner. HLC does not acquire the claim itself — HLC funds the acquisition.
The Purchaser forms a dedicated Special Purpose Vehicle (SPV), which acquires the Target Claim using HLC's capital. The Purchaser then pursues the claim through separately arranged litigation funding. HLC holds a first-priority security interest in the claim and all proceeds.
"HLC does not acquire the claim. HLC finances the acquisition — providing disciplined capital to investors who do."
A non-refundable origination fee is paid by the Purchaser to HLC before any capital is advanced. Specific terms are agreed at underwriting.
HLC's return is structured as an agreed multiple on the funded amount, paid from Gross Proceeds after principal repayment.
In the Target Claim, the Acquisition Agreement, and all Gross Proceeds.
Standard eligibility range for CPF transactions.
Purchaser requirement: The Purchaser must have independently arranged litigation funding for case expenses. The Origination Fee must be sourced from the Purchaser's own funds — it cannot be borrowed from HLC's advance.
| Feature | Litigation Funding LFA · Product I |
Claim Purchase Funding CPF · Product II |
|---|---|---|
| HLC's counterparty | Original claimant | Purchaser (investor) |
| What HLC provides | Capital for legal costs | Capital to acquire the claim |
| Upfront fee | None — ever | Origination fee (pre-funding) |
| HLC return | Success-only, from proceeds | Agreed multiple on funded amount |
| HLC disclosed? | Yes — as funder | To Purchaser only |
| Claimant retains title | Yes — fully | No — transfers to Purchaser SPV |
| Claim size | Commercial matters | $5M – $50M est. recovery |
| Non-recourse | Yes — if case fails | Not applicable (investor product) |
HLC is not a high-volume originator. We are a disciplined, capital-preservation-first institution. We do not charge fees to assess claims. We do not direct litigation strategy. We do not seek to become visible participants in proceedings we fund.
Every transaction is reviewed by our Investment Committee, which applies a consistent underwriting doctrine across both products. Capital preservation comes first — return generation is secondary.
HLC does not direct legal strategy, instruct counsel, or participate in settlement negotiations beyond its contractual consent rights. Legal decisions belong to the claimant and their counsel — exclusively.
Every capital deployment requires IC approval against a documented underwriting standard — probability assessment, enforcement scoring, budget stress testing, and portfolio concentration review.
HLC does not disclose its portfolio, its claimants, or its terms to any third party. All engagements are conducted on a strictly confidential basis without exception.
We require a high, independently assessed probability of success. We do not fund speculative, unmeritorious, or marginal claims. Counsel's assessment is a required starting point for every matter.
A favourable judgment or award must be capable of enforcement. We conduct a rigorous analysis of defendant asset position, jurisdiction, and the practical path to recovery. We do not fund claims against judgment-proof defendants.
Expected damages must materially exceed the capital HLC deploys. The return profile must justify the risk, the timeline, and HLC's opportunity cost. Capital efficiency is assessed across both products.
Before any underwriting resources are committed, a claimant must have retained counsel, have a substantive claim document, and be able to provide a good-faith budget and timeline. This is non-negotiable across both products.
All claimants, defendants, and counterparties are screened against applicable sanctions lists prior to any engagement. No exceptions.
HLC operates on a strict enquiry basis. We do not solicit. All initial enquiries are held in the strictest confidence and are subject to a confidentiality agreement prior to any substantive discussion.
If you are acting for a claimant and wish to explore whether funding may be suitable for your client's matter, HLC welcomes a brief, non-privileged summary submitted on their behalf. Counsel referrals are how most HLC engagements begin. You do not need your client's matter to be at an advanced stage — early-stage assessment discussions are welcomed. HLC treats all referral information with strict confidentiality and will not approach your client directly without your express consent.
Submit a brief, non-privileged summary of your matter using the form below or by email. Include jurisdiction, procedural posture, estimated damages, capital sought, and counsel contact information.
If your matter passes our initial screen, we will request supporting materials and a probability assessment from counsel. HLC bears its own review costs at all stages.
Qualifying matters proceed to full underwriting. If approved, we will issue a Term Sheet. Do not transmit privileged memoranda until a confidentiality agreement is in place.
Prospective claimants, counsel, and investors may submit an enquiry using the form or contact us directly. All communications are treated with strict confidentiality and do not create any legal or financial obligation on either party.